- Home
- ZS vs DXCM Comparison
ZS vs DXCM Comparison
Compare ZS & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZS
- DXCM
- Stock Information
- Founded
- ZS 2007
- DXCM 1999
- Country
- ZS United States
- DXCM United States
- Employees
- ZS N/A
- DXCM N/A
- Industry
- ZS EDP Services
- DXCM Medical/Dental Instruments
- Sector
- ZS Technology
- DXCM Health Care
- Exchange
- ZS Nasdaq
- DXCM Nasdaq
- Market Cap
- ZS 31.7B
- DXCM 28.0B
- IPO Year
- ZS 2018
- DXCM 2005
- Fundamental
- Price
- ZS $186.86
- DXCM $80.21
- Analyst Decision
- ZS Buy
- DXCM Buy
- Analyst Count
- ZS 35
- DXCM 17
- Target Price
- ZS $226.21
- DXCM $98.00
- AVG Volume (30 Days)
- ZS 2.5M
- DXCM 3.4M
- Earning Date
- ZS 12-02-2024
- DXCM 02-06-2025
- Dividend Yield
- ZS N/A
- DXCM N/A
- EPS Growth
- ZS N/A
- DXCM 83.21
- EPS
- ZS N/A
- DXCM 1.67
- Revenue
- ZS $2,299,023,000.00
- DXCM $3,954,000,000.00
- Revenue This Year
- ZS $25.34
- DXCM $13.10
- Revenue Next Year
- ZS $20.57
- DXCM $14.74
- P/E Ratio
- ZS N/A
- DXCM $48.12
- Revenue Growth
- ZS 30.77
- DXCM 16.19
- 52 Week Low
- ZS $153.45
- DXCM $62.34
- 52 Week High
- ZS $259.61
- DXCM $142.00
- Technical
- Relative Strength Index (RSI)
- ZS 40.94
- DXCM 57.98
- Support Level
- ZS $179.11
- DXCM $74.50
- Resistance Level
- ZS $209.39
- DXCM $80.83
- Average True Range (ATR)
- ZS 7.10
- DXCM 2.41
- MACD
- ZS -2.43
- DXCM -0.04
- Stochastic Oscillator
- ZS 20.62
- DXCM 78.46
About ZS Zscaler Inc.
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.